Form 4 for FHTX Foghorn Therapeutics Inc.
Accepted 2025-04-10 00:00:00 ET · period of report 2025-04-09 · accession 0001562180-25-003092 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-04-10 | 2025-04-09 | FHTX | GOTTSCHALK ADRIAN | CEO, Dir | G - Gift | $0.00 | 0 | 511.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-09 | G | D | 197,906 | $0.00 | 511,704 | I See Footnote | — | — | (F2) Consists of 47,497 shares held by the Gottschalk 2023 GRAT and 464,207 shares held by the Gottschalk Living Trust. |
| 2 | Common | Common Stock | 2025-04-09 | G | A | 197,906 | $0.00 | 511,704 | I See Footnote | — | — | (F2) Consists of 47,497 shares held by the Gottschalk 2023 GRAT and 464,207 shares held by the Gottschalk Living Trust. |